• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症患者免疫反应性的体外特征分析

In vitro characterization of immunological responsiveness of uremic patients.

作者信息

Kunori T, Fehrman I, Ringdén O, Möller E

出版信息

Nephron. 1980;26(5):234-9. doi: 10.1159/000181991.

DOI:10.1159/000181991
PMID:6448353
Abstract

Uremic patients are thought to have deficient immune reactivity. The mechanisms for immunosuppression are not known. We have studied various in vitro immune response parameters in lymphocytes from uremic patients and from healthy controls. Using polyclonal activating substances, it was found that PHA and LPS responses were reduced in cells from the patient group compared to the control group (p < 0.05). Furthermore, MLC responsiveness using pooled stimulator cells and polyclonal antibody secretion induced by Staphylococcus aureus bacteria in vitro were reduced in the patients (p < 0.05). No differences with regard to proportions of T/B cells in blood were noted between the two groups. No correlation was found between responses of individual cells to different activating substances, with the exception of PHA and ConA. However, low responses to PHA were usually accompanied by a general low responsiveness. Patients were further subdivided into groups according to the type of dialysis treatment, peritoneal dialysis (PD) or hemodialysis (HD), and to the duration of the hemodialysis period (< and > 1 year). Patients treated with PD showed impaired T cell reactivity with loer PHA responses compared to the HD patients (p < 0.05). Between the HD groups there were no significant differences in mitogen or MLC responses. We believe that the differences between PD and HD were due to the facts that the PD patients were older and not in the same nutritional state as the HD patients.

摘要

尿毒症患者被认为存在免疫反应性缺陷。免疫抑制的机制尚不清楚。我们研究了尿毒症患者和健康对照者淋巴细胞的各种体外免疫反应参数。使用多克隆激活物质发现,与对照组相比,患者组细胞的PHA和LPS反应降低(p<0.05)。此外,患者使用混合刺激细胞的MLC反应性以及金黄色葡萄球菌体外诱导的多克隆抗体分泌降低(p<0.05)。两组之间血液中T/B细胞比例无差异。除了PHA和ConA外,未发现单个细胞对不同激活物质的反应之间存在相关性。然而,对PHA的低反应通常伴随着普遍的低反应性。患者根据透析治疗类型(腹膜透析(PD)或血液透析(HD))以及血液透析期的持续时间(<1年和>1年)进一步分组。与HD患者相比,接受PD治疗的患者T细胞反应性受损且PHA反应较低(p<0.05)。HD组之间在有丝分裂原或MLC反应方面无显著差异。我们认为PD和HD之间的差异是由于PD患者年龄较大且营养状态与HD患者不同。

相似文献

1
In vitro characterization of immunological responsiveness of uremic patients.尿毒症患者免疫反应性的体外特征分析
Nephron. 1980;26(5):234-9. doi: 10.1159/000181991.
2
Lymphocytes from multitransfused uremic patients have poor MLC reactivity.多次输血的尿毒症患者的淋巴细胞具有较差的混合淋巴细胞培养反应性。
Tissue Antigens. 1981;17(4):386-95. doi: 10.1111/j.1399-0039.1981.tb00720.x.
3
Monocyte-mediated suppression of mitogen responses of lymphocytes in uremic patients.尿毒症患者中单核细胞介导的淋巴细胞有丝分裂原反应抑制作用。
Nephron. 1983;34(2):87-92. doi: 10.1159/000182988.
4
Uremia as a state of immune deficiency.
Scand J Immunol. 1976;5(1-2):107-15. doi: 10.1111/j.1365-3083.1976.tb02997.x.
5
Immune dysfunction in uremia.尿毒症中的免疫功能障碍。
Kidney Int Suppl. 1997 Nov;62:S79-82.
6
Derangement of humoral immune system in nondialyzed uremic patients.未透析尿毒症患者体液免疫系统的紊乱。
Jpn J Med. 1984 Feb;23(1):9-15. doi: 10.2169/internalmedicine1962.23.9.
7
[Abnormalities of cellular immunity in uremic patients].
Nihon Jinzo Gakkai Shi. 1993 Jun;35(6):733-42.
8
Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis.
Proc Eur Dial Transplant Assoc. 1983;20:230-5.
9
Differential glucocorticoid responsiveness of dialysis patients' lymphocytes.透析患者淋巴细胞的糖皮质激素反应差异
Perit Dial Int. 1996 Jul-Aug;16(4):406-11.
10
Immunological studies in uremic and kidney transplanted patients.尿毒症患者及肾移植患者的免疫学研究。
Dan Med Bull. 1989 Apr;36(2):160-75.

引用本文的文献

1
Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit.儿科透析病房中SARS-CoV-2的纵向血清转化及功能异质性
Kidney Int. 2021 Feb;99(2):484-486. doi: 10.1016/j.kint.2020.11.014.
2
Studies on IL-2 production and T-cell colony forming unit in patients with chronic renal failure.慢性肾衰竭患者白细胞介素-2产生及T细胞集落形成单位的研究
Korean J Intern Med. 1993 Jul;8(2):86-92. doi: 10.3904/kjim.1993.8.2.86.
3
Impact of long-term hemodialysis on nutritional status in patients with end-stage renal failure.
长期血液透析对终末期肾衰竭患者营养状况的影响。
Clin Investig. 1994 Oct;72(10):754-61. doi: 10.1007/BF00180542.
4
Humoral inhibitors of the immune response in uremia. V. Induction of suppressor cells in vitro by uremic serum.尿毒症中免疫反应的体液抑制剂。V. 尿毒症血清在体外诱导抑制细胞
Am J Pathol. 1983 May;111(2):149-55.
5
Antibody production and antigenic specific suppression to bovine serum albumin in uremic rats.尿毒症大鼠体内针对牛血清白蛋白的抗体产生及抗原特异性抑制
Clin Exp Immunol. 1982 Apr;48(1):111-7.
6
Impaired in vitro growth of PHA induced T lymphocyte colonies in hemodialyzed renal failure patients.血液透析的肾衰竭患者中,PHA诱导的T淋巴细胞集落的体外生长受损。
Blut. 1985 Mar;50(3):135-40. doi: 10.1007/BF00320069.
7
In vitro analysis of B lymphocyte function in uraemia.尿毒症患者B淋巴细胞功能的体外分析
Clin Exp Immunol. 1987 Nov;70(2):463-70.
8
The use of vaccines in renal failure.肾衰竭中疫苗的使用。
Clin Pharmacokinet. 1992 Jun;22(6):434-46. doi: 10.2165/00003088-199222060-00003.